Tricuspid regurgitation (TR) is associated with high morbidity and mortality rates with limited treatment options. We report one- and two-year outcomes of the Cardioband tricuspid valve reconstruction system in the treatment of ≥moderate functional TR in the TRI-REPAIR study.

Two-year Outcomes with the Cardioband Tricuspid System from the Multicentre, Prospective TRI-REPAIR Study / Nickenig, G., Weber, M., Schüler, R., Hausleiter, J., Nabauer, M., von Bardeleben, R.S., Sotiriou, E., Schäfer, U., Deuschl, F., Alessandrini, H., Kreidel, F., Juliard, J., Brochet, E., Latib, A., Montorfano, M., Agricola, E., Baldus, S., Friedrichs, K.P., Deo, S.H., Gilmore, S.Y., et al.. - In: EUROINTERVENTION. - ISSN 1969-6213. - (2021). [10.4244/EIJ-D-20-01107]

Two-year Outcomes with the Cardioband Tricuspid System from the Multicentre, Prospective TRI-REPAIR Study

Montorfano, Matteo;Agricola, Eustachio;Maisano, Francesco
2021-01-01

Abstract

Tricuspid regurgitation (TR) is associated with high morbidity and mortality rates with limited treatment options. We report one- and two-year outcomes of the Cardioband tricuspid valve reconstruction system in the treatment of ≥moderate functional TR in the TRI-REPAIR study.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/105614
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 176
  • ???jsp.display-item.citation.isi??? 160
social impact